These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 36539364)
21. Circ_0007385 regulates cell proliferation, apoptosis and stemness via targeting miR-493-3p/RAB22A axis in non-small cell lung cancer. Ding D; Yang F; Chen Z; Ying J Thorac Cancer; 2022 Feb; 13(4):571-581. PubMed ID: 34989145 [TBL] [Abstract][Full Text] [Related]
22. Circ_0006220 Contributes to NSCLC Progression through miR-342-3p/GOT2 Axis. Tang J; Li X; Zhao L; Hui J; Ding N Ann Thorac Cardiovasc Surg; 2023 Feb; 29(1):11-22. PubMed ID: 36575008 [TBL] [Abstract][Full Text] [Related]
23. Circ_0074027 Contributes to Non-Small Cell Lung Cancer Progression by Upregulating Yu C; Ying J; Yu K; Shen W; Jiang M Cancer Biother Radiopharm; 2022 Mar; 37(2):73-83. PubMed ID: 32580576 [No Abstract] [Full Text] [Related]
24. CircRNA hsa_circ_0070659 predicts poor prognosis and promotes non-small cell lung cancer (NSCLC) progression via microRNA-377 (miR-377) / Ras-Associated Binding Protein 3C (RAB3C) pathway. Meng Q; Li Y; Sun Z; Yang X Bioengineered; 2022 Jun; 13(6):14578-14594. PubMed ID: 36694911 [TBL] [Abstract][Full Text] [Related]
25. Circular RNA hsa_circ_0008003 promotes the progression of non-small-cell lung cancer by sponging miR-548I and regulating KPNA4 expression. Yang W; Yao Y; Yang S; Ke Y Thorac Cancer; 2023 Feb; 14(6):544-554. PubMed ID: 36573325 [TBL] [Abstract][Full Text] [Related]
26. Circ_0074027 contributes to non-small cell lung cancer progression through positively modulating RHOA via sequestering miR-2467-3p. Duan Z; Wei S; Liu Y J Bioenerg Biomembr; 2021 Apr; 53(2):223-233. PubMed ID: 33687619 [TBL] [Abstract][Full Text] [Related]
27. Circ_0091537 promotes gefitinib chemoresistance in non-small cell lung cancer by mediating the miR-520h/YAP1 network. Qu R; Ma J Anticancer Drugs; 2023 Nov; 34(10):1151-1161. PubMed ID: 36727737 [TBL] [Abstract][Full Text] [Related]
28. Circ_0006006 facilitates non-small cell lung cancer progression by modulating miR-924/SRSF7 axis. Xu Q; Shi J; Zhang L; Sheng Y; Zhang Y; Chu D; Xu A J Gene Med; 2022 May; 24(5):e3411. PubMed ID: 35037349 [TBL] [Abstract][Full Text] [Related]
29. Circ_0020123 enhances the cisplatin resistance in non-small cell lung cancer cells partly by sponging miR-140-3p to regulate homeobox B5 (HOXB5). Wei D; Zeng J; Rong F; Xu Y; Wei R; Zou C Bioengineered; 2022 Mar; 13(3):5126-5140. PubMed ID: 35170372 [TBL] [Abstract][Full Text] [Related]
30. Circular RNA circ_0006168 enhances Taxol resistance in esophageal squamous cell carcinoma by regulating miR-194-5p/JMJD1C axis. Qu F; Wang L; Wang C; Yu L; Zhao K; Zhong H Cancer Cell Int; 2021 May; 21(1):273. PubMed ID: 34022910 [TBL] [Abstract][Full Text] [Related]
31. Circ-RNF111 contributes to paclitaxel resistance in breast cancer by elevating E2F3 expression via miR-140-5p. Zang H; Li Y; Zhang X; Huang G Thorac Cancer; 2020 Jul; 11(7):1891-1903. PubMed ID: 32445273 [TBL] [Abstract][Full Text] [Related]
32. Circular RNA circ_0001287 inhibits the proliferation, metastasis, and radiosensitivity of non-small cell lung cancer cells by sponging microRNA miR-21 and up-regulating phosphatase and tensin homolog expression. Zhang CC; Li Y; Feng XZ; Li DB Bioengineered; 2021 Dec; 12(1):414-425. PubMed ID: 33467964 [TBL] [Abstract][Full Text] [Related]
33. Serum Exosomes-Based Biomarker circ_0008928 Regulates Cisplatin Sensitivity, Tumor Progression, and Glycolysis Metabolism by miR-488/ Shi Q; Ji T; Ma Z; Tan Q; Liang J Cancer Biother Radiopharm; 2023 Oct; 38(8):558-571. PubMed ID: 33661058 [No Abstract] [Full Text] [Related]
34. Circ_0067934 promotes non-small cell lung cancer development by regulating miR-1182/KLF8 axis and activating Wnt/β-catenin pathway. Zhao M; Ma W; Ma C Biomed Pharmacother; 2020 Sep; 129():110461. PubMed ID: 32768951 [TBL] [Abstract][Full Text] [Related]
35. Cisplatin resistance and malignant behaviors of lung cancer cells are promoted by circ_0002360 via targeting miR-6751-3p to regulate the expression of ZNF300. Ding L; Li L; Tang Z Thorac Cancer; 2022 Apr; 13(7):986-996. PubMed ID: 35166026 [TBL] [Abstract][Full Text] [Related]
36. Circ_0000735 enhances the proliferation, metastasis and glycolysis of non-small cell lung cancer by regulating the miR-635/FAM83F axis. Tai G; Zhang M; Liu F Exp Lung Res; 2021 Apr; 47(3):136-148. PubMed ID: 33560141 [TBL] [Abstract][Full Text] [Related]
37. Circ_0002476 regulates cell growth, invasion, and mtDNA damage in non-small cell lung cancer by targeting miR-1182/TFAM axis. Wang W; Sun H; Ma X; Zhu T; Zhang H Thorac Cancer; 2022 Oct; 13(20):2867-2878. PubMed ID: 36056804 [TBL] [Abstract][Full Text] [Related]
38. Circ_SETD3 regulates gefitinib sensitivity and tumor progression by miR-873-5p-dependent regulation of APPBP2 in non-small cell lung cancer. Sheng J; Liu L; Dong T; Wu X J Chemother; 2022 Oct; 34(6):401-413. PubMed ID: 34861803 [TBL] [Abstract][Full Text] [Related]
39. Circ_0079530 stimulates THBS2 to promote the malignant progression of non-small cell lung cancer by sponging miR-584-5p. Fang K; Deng Y; Yang P; Zhang Y; Luo D; Wang F; Cai Z; Liu Y Histol Histopathol; 2023 Jun; 38(6):681-693. PubMed ID: 36382967 [TBL] [Abstract][Full Text] [Related]
40. Circ_0004015 silencing represses cisplatin chemoresistance and tumor progression by reducing KLF8 in a miR-198-dependent manner in non-small cell lung cancer. Li Y; Yang X; Xiong X Genomics; 2022 Mar; 114(2):110294. PubMed ID: 35134495 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]